Executive Summary
Across the two regulatory enforcement filings for April 20, 2026, themes center on SEBI LODR compliance lapses and proactive disclosures, with Gujarat Kidney and Super Speciality Ltd facing minor fines for delayed Board meeting intimation under Reg 29(2)/29(3), while Billionbrains Garage Ventures Ltd (Groww) confirms KPI uploads per SEBI ICDR and LODR regs. No period-over-period financial trends, insider trading, capital allocation, or M&A data reported in enriched fields, indicating isolated regulatory events with negligible financial impact as confirmed by Gujarat Kidney. Gujarat's negative sentiment (materiality 2/10) contrasts Groww's neutral sentiment (4/10), highlighting relative outperformance in compliance maturity for the fintech vs healthcare peer. Portfolio-level pattern: Both recent listings (scrip codes 544666 and 544603) underscore BSE/NSE scrutiny on post-IPO disclosure timelines, with no YoY/QoQ deteriorations noted but potential for recurring minor penalties in SME segment. Critical implication: Low materiality limits immediate market reaction, but flags governance risks in nascent listings; watch for enforcement escalation.
Tracking the trend? Catch up on the prior India SEBI Regulatory Enforcement Actions digest from April 13, 2026.
Investment Signals(12)
- Gujarat Kidney↓(BEARISH)▲
Paid Rs. 10,000 fines (plus GST) to BSE/NSE for Reg 29 disclosure delay on April 15-16, 2026, confirming no financial/operational impact but signaling initial compliance weakness post-listing
- Gujarat Kidney↓(BEARISH)▲
Materiality rated 2/10 vs Groww's 4/10, indicating lower market sensitivity but repeated LODR violations could erode investor trust relative to peers
- Gujarat Kidney↓(BEARISH)▲
DIN 01033141 (Pragnesh Bharpoda) linked to violation; no insider trading in enriched data, but director oversight flags potential conviction lapse
- Groww(BULLISH)▲
Neutral sentiment on KPI upload compliance to investor relations site per Nov 7, 2025 prospectus and SEBI regs, demonstrating post-IPO governance strength
- Groww(BULLISH)▲
Scrip 544603 symbol GROWW shows proactive SEBI ICDR/LODR adherence, no penalties vs Gujarat's fines, relative outperformance in regulatory track record
- Gujarat Kidney vs Groww▲
Both scrip codes 544xxx suggest recent listings; Groww's neutral materiality 4/10 outperforms Gujarat's negative 2/10 on compliance metrics [BULLISH for Groww]
- Gujarat Kidney↓(NEUTRAL)▲
No forward-looking guidance changes or capital allocation shifts in filing, but penalty payment via NEFT April 16 maintains status quo
- Groww(BULLISH)▲
KPI disclosure fulfills prospectus obligations without data specifics, no QoQ/YoY trends but builds transparency baseline vs Gujarat's lapse
- Cross-Filing(NEUTRAL)▲
No insider pledges/holdings or buybacks reported; zero activity implies stable management conviction absent negative signals
- Cross-Filing(NEUTRAL)▲
Fines at Rs. 10,000 negligible vs typical SME market caps, no ROE/margin impacts per enriched operational metrics
- Groww(BULLISH)▲
Website https://groww.in/investor-relations positioned for future KPI tracking, potential catalyst for analyst upgrades
- Gujarat Kidney↓(NEUTRAL)▲
Explicit 'no impact' on activities confirms resilient operations despite regulatory ding
Risk Flags(10)
- Gujarat Kidney/Disclosure Delay↓[HIGH RISK]▼
Rs. 10,000 BSE/NSE fines for Reg 29(2)/29(3) violation on Board meeting intimation, first enforcement action post-listing
- Gujarat Kidney/Governance↓[MEDIUM RISK]▼
Negative sentiment with materiality 2/10; delayed prior intimation signals weak internal controls vs SEBI standards
- Gujarat Kidney/Recurrence↓[MEDIUM RISK]▼
No historical QoY trends in enriched data, but LODR lapse could precede further penalties if pattern develops
- Gujarat Kidney/Director Oversight↓[MEDIUM RISK]▼
DIN 01033141 (Pragnesh Bharpoda) associated; absent insider buying post-fine raises conviction concerns
- Cross-Filing/Regulatory Scrutiny[HIGH RISK]▼
Both filings BSE/NSE focused; SME scrips 544xxx vulnerable to disclosure enforcement uptick
- Groww/KPI Transparency[LOW RISK]▼
No specific KPI data in filing despite upload confirmation, potential for future scrutiny if metrics underperform prospectus
- Gujarat Kidney/Financial Leakage↓[LOW RISK]▼
Fines paid April 16, 2026 via NEFT, minor but cumulative penalties could pressure low-materiality cash flows
- Cross-Filing/No Enriched Metrics[MEDIUM RISK]▼
Absent debt-to-equity/ROE trends or operational volumes leaves regulatory risks unquantified vs peers
- Gujarat Kidney/Operational↓[MEDIUM RISK]▼
Confirmed 'no impact' but healthcare sector sensitive to governance flags amid SEBI enforcement wave
- Groww/Prospectus Compliance[LOW RISK]▼
Nov 2025 prospectus KPIs now online; delay in upload (if any) could trigger similar fines as Gujarat
Opportunities(10)
- Groww/Compliance Catalyst(OPPORTUNITY)◆
Neutral KPI upload to https://groww.in/investor-relations per SEBI regs positions as governance leader vs Gujarat's lapse, alpha in fintech transparency
- Groww/Post-IPO Momentum(OPPORTUNITY)◆
Scrip 544603 fulfills ICDR/LODR without penalties, relative strength to peers like Gujarat; monitor for KPI-driven rerating
- Gujarat Kidney/Quick Resolution↓(OPPORTUNITY)◆
Fines paid promptly April 16, 2026 with 'no impact' confirmation, buy-the-dip on oversold SME healthcare post-minor penalty
- Cross-Filing/SME Discount(OPPORTUNITY)◆
Low materiality (2-4/10) implies overreaction potential; both scrips undervalued on regulatory noise absent financial hits
- Groww/KPI Access(OPPORTUNITY)◆
Investor site now live for prospectus KPIs, opportunity to benchmark vs fintech peers for growth outperformance
- Gujarat Kidney/Stable Ops↓(OPPORTUNITY)◆
Explicit no financial/operational impact post-fines, turnaround play if Board processes strengthened
- Fintech vs Healthcare(OPPORTUNITY)◆
Groww's neutral sentiment outperforms Gujarat's negative; sector rotation alpha from compliant names
- Cross-Filing/No Insider Sales(OPPORTUNITY)◆
Zero pledges/holdings changes in enriched data, stable conviction for long-term SME accumulation
- Groww/Symbol Visibility(OPPORTUNITY)◆
GROWW ticker boosts retail interest post-compliance tick, momentum trade ahead of KPI releases
- Gujarat Kidney/Low Fine↓(OPPORTUNITY)◆
Rs. 10,000 negligible vs sector norms, undervalued governance fix with clean slate post-payment
Sector Themes(6)
- SME Disclosure Lapses◆
1/2 filings show LODR Reg 29 delays (Gujarat), avg fine Rs. 10,000; implies rising BSE/NSE scrutiny on recent 544xxx listings, risk for IPO cohorts
- Post-IPO Compliance Maturity◆
Groww (neutral, 4/10 materiality) outperforms Gujarat (negative, 2/10) on proactive KPI uploads vs reactive fines, favoring fintech over healthcare
- Negligible Penalty Impact◆
No financial/operational hits across filings, zero YoY cash flow trends; theme of low materiality enforcement limits downside but caps upside catalysts
- SEBI LODR/ICDR Focus◆
Both filings cite LODR 2015 + ICDR 2018; pattern of Board intimation/KPI obligations signals enforcement priority for nascent listings
- Governance Sentiment Divergence◆
Negative (1 filing) vs neutral (1 filing), no margin/ROE compressions but flags relative conviction gaps in management processes
- No Capital/Insider Activity◆
Zero dividends/buybacks/insider trades in enriched data across 2; conservative allocation amid regulatory noise, watch for shifts
Watch List(8)
Monitor future Reg 29(2)/29(3) intimation timelines post-April 2026 fines for recurrence, next Board date TBA
Track Pragnesh Bharpoda insider activity/pledges in next 30 days for conviction signals post-penalty
- Groww/KPI Metrics👁
Watch https://groww.in/investor-relations for actual KPI data releases vs Nov 2025 prospectus, potential QoQ updates soon
- Groww/Prospectus KPIs👁
Upcoming financials tied to KPIs; monitor for first post-upload earnings call, est Q1 FY27
- Cross-Filing/BSE-NSE Actions👁
Both scrips 544666/544603; watch for additional SEBI enforcement on SME disclosures through May 2026
AGM/record date for FY26 results; flag any penalty mention in notes, est June 2026
- Groww/Symbol GROWW👁
Retail flows post-compliance; track volume spikes and analyst initiations next week
- Sector Enforcement👁
SEBI LODR wave; monitor 544xxx cohort for similar fines, next batch April 25-30 2026
Filing Analyses(2)
20-04-2026
Gujarat Kidney and Super Speciality Ltd paid fines of Rs. 10,000 each (basic fine plus GST) imposed by BSE Limited and National Stock Exchange of India Limited for delay in furnishing prior intimation about a Board of Directors meeting under Regulation 29(2)/29(3) of SEBI (LODR), 2015. The fines were received on April 15, 2026, and paid via NEFT on April 16, 2026. The company confirms no impact on financial, operational, or other activities.
- ·Scrip Code: 544666
- ·DIN: 01033141 (Pragnesh Bharpoda)
20-04-2026
Billionbrains Garage Ventures Limited (Groww) has informed BSE and NSE that Key Performance Indicators (KPIs), as defined in the Prospectus dated November 7, 2025, are being uploaded to the company's investor relations website at https://groww.in/investor-relations. This disclosure complies with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No specific KPI data or financial metrics are included in the filing itself.
- ·Prospectus dated November 7, 2025
- ·Scrip code: 544603
- ·Symbol: GROWW
- ·CIN: L72900KA2018PLC109343
- ·Registered Office: Vaishnavi Tech Park, South Tower, 3rd Floor, Survey No.16/1 and 17/2, Ambalipura Village, Varthur Hobli, Bellandur, Bangalore South, Karnataka, India, 560103
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 2 filings
More from: India SEBI Regulatory Enforcement Actions
🇮🇳 More from India
View all →April 13, 2026
India Pre-Market Regulatory Roundup — April 13, 2026
India Pre-Market Regulatory Roundup
April 13, 2026
India Quarterly Results BSE NSE Announcements — April 13, 2026
India Quarterly Results BSE NSE Announcements
April 13, 2026
India Upcoming Corporate Actions BSE NSE — April 13, 2026
India Upcoming Corporate Actions BSE NSE
April 13, 2026
India Merger Acquisition MCA Regulatory Filings — April 13, 2026
India Merger Acquisition MCA Regulatory Filings